Navigation Links
Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes
Date:11/18/2010

CHADDS FORD, Pa., Nov. 18, 2010 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals Holdings Inc. (Nasdaq: ENDP) today announced that it priced $400 million aggregate principal amount of 7.00% senior unsecured notes due 2020 at an issue price of 99.10 percent in connection with its previously announced private offering. The notes will be unsecured, unsubordinated obligations of the Company and will be guaranteed by certain of the Company's domestic subsidiaries.  Subject to customary closing conditions, this offering is expected to close on November 23, 2010.

Endo intends to use the net proceeds of this offering to partially finance the pending acquisition of Qualitest Pharmaceuticals, and to pay related fees and expenses. This offering is not conditioned on the acquisition of Qualitest and if it is not consummated, the proceeds from this offering would instead be used for general corporate purposes.

The notes and the related subsidiary guarantees have not been registered under the Securities Act of 1933 as amended or any applicable state securities laws, and will be offered only to qualified institutional buyers in reliance on Rule 144A, and outside the United States in compliance with Regulation S under the Securities Act. Unless so registered, the notes and the related subsidiary guarantees may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievem
'/>"/>

SOURCE Endo Pharmaceuticals Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/sn8mlw/picture_archiving ) has announced the ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... the period 2014 through 2020. Also, a seven-year historic analysis ...
(Date:6/2/2015)... ATLANTA , June 2, 2015 ... (CSTE) joins over 150 major food companies, retailers, ... White House Forum on Antibiotic Stewardship. CSTE is ... of antibiotic-resistant bacteria, detect resistant strains, preserve the ... spread of resistant infections. CSTE continues ...
(Date:6/2/2015)... 2015 San MediTech, the industry leader in ... (CGM) for diabetics, announced its plan to attend the ... Boston on June 5 th ... Glucose Monitoring System (DGMS). The company plans to show ... innovative technologies and advancements made by Chinese medical device ...
Breaking Medicine Technology:Picture Archiving and Communication Systems (PACS) - Global Strategic Business Report 2015: User Demand Favors Integrated RIS/PACS Solutions 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 2San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 3San MediTech Showcases Smart Glucose Management Cloud Database at 75th ADA 4
... Atrium Medical Corporation today announced that it is a ... by the Premier healthcare alliance . Premier ... one of 39 contracted suppliers to receive the Pinnacle Award. ... and their drive toward the mutual goal of providing clinical ...
... , Altair Semiconductor ( http://www.altair-semi.com ),the ... high performance 4G LTE,chipsets , announced today ... developed by AsiaTelco Technologies, achieved,download speeds of more ... in a live over-the-air demonstration requested by executives,from ...
Cached Medicine Technology:Atrium Honored by the Premier Healthcare Alliance for Operational Excellence 2Atrium Honored by the Premier Healthcare Alliance for Operational Excellence 3Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives 2Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives 3
(Date:6/3/2015)... 03, 2015 Foot and Ankle ... Casey Friske ( Clarksville Division ) was recently ... Symposium of Advanced Wound Care (SAWC) and the American ... Dan Davis. The Conference was held on April ... Center in San Antonio, TX. , Dr. Casey ...
(Date:6/3/2015)... Veatch Consulting Services is excited to announce ... for business in April 2006, they have made it ... clients. Each and every year they have worked diligently ... to say that they are off to a great ... added this year is the Customer Review site veatchconsultingreviews.weebly.com. ...
(Date:6/3/2015)... Israel (PRWEB) June 03, 2015 ... emergency mass-notification, multi-channel solutions, reported of its "behind-the-scenes" ... the past few months. Since March this year, ... has been inflicting the South-American country, putting millions ... ash and gas into the atmosphere. "evigilo's technology, ...
(Date:6/2/2015)... BALTIMORE, Md. – Ellarea Maria Cole ... wellness after being diagnosed with lupus. In spite of ... changes which enhance health, lupus and other autoimmune related ... for Wellness ,” she offers a holistic approach to ... provides an overview of some autoimmune diseases—especially lupus ...
(Date:6/2/2015)... 2015 The organic cotton market is ... an annual study conducted by Textile Exchange, an international ... The report, released today, encompasses extensive data about organic ... level and also takes the opportunity to celebrate those ... , The last several years have been complicated ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Thousands of Lives Saved, Millions Protected in Chile 2Health News:New book offers holistic approach in living with autoimmune diseases 2Health News:New book offers holistic approach in living with autoimmune diseases 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5
... Bradford, from Oswestry, a patient with breast cancer in England ... are given free drug treatment// at a hospital. Local health ... the Shropshire Primary Care Trust. The patients in Shropshire have ... protest at the hospital on Monday. ,North Shropshire ...
... London, the cause of autism may now be explained due t ... not interacting well with other people. Weak links between brain areas ... situations as well as other people. ,The study ... an Autism Spectrum Disorder (ASD) while the other 16 did not. ...
... NHS trust failed to adequately supervise two doctors. Amit ... Hospital. It led to the death of the patient ... surgery. He suffered toxic shock syndrome. The hospital ... house officers. ,At a sentencing hearing at ...
... According to a new study of women with early stage, ... disease have been identified that may influence how patients are ... patients from 1988 to 2002 was reviewed by Cancer Research ... are risk factors for invasive disease and the pattern of ...
... Office (NHSO) has found that women aged above 35 are ... should annually undergo a Pap smear test for early detection ... is the most common type of cancer among women. ... scheme, has provided Pap smear services to 1.5 million women ...
... heart's largest artery, the aorta. Studies were going on to ... Johns Hopkins University// have successfully come up with the treatment. ... in recent studies for treating the genetic disorder. The ... appears to prevent the weakening of the heart's largest artery, ...
Cached Medicine News:Health News:Cancer Patients Protest For Free Drug Treatment 2Health News:Lack Of Communication Between Brain Areas Can Cause Autism 2
Do More with your Workforce. Technology That Makes Walkaway Automation a Reality. Engineered for Accurate Results. Multiple Levels of Control Reduce Contamination. Flexible Sample Preparation Platfor...
... 3100 system offers continuous, unattended operation ... separation and detection, and data analysis. ... and importing sample information, the operator ... Run command. The instrument requires no ...
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
... is,a no-extraction, solid-phase 125I,radioimmunoassay ... use in the quantitative,measurement ... for the,differential diagnosis of ... ovulation induction with,and without ...
Medicine Products: